HNGE Hinge Health, Inc.
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.…
Industry Peers
Health Information ServicesKey Statistics
About Hinge Health (NYSE: HNGE)
›
Hinge Health (NYSE: HNGE) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 1,437 employees.
The shares were at 105.78 USD on 20 November 2026, up 139.9% over 52 weeks. Its 52-week range is 30.08 USD to 126.40 USD: the price is 16.3% below the high and 251.7% above the low.
At a market capitalisation of 8.60B USD, it trades at 28.7 times trailing earnings and 32.5 times forward earnings. The median trailing P/E of its 15 largest Health Information Services peers is 43.6, a discount of 34% for HNGE.
Hinge Health reports return on equity of -139.6%, an operating margin of 18.8% and revenue up 52.4% year over year.
It holds more cash than debt, a net cash position of 260.78M USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 16 analysts cover the stock, with an average rating of Buy; their mean price target of 135.38 USD is 28.0% above the current price. The next earnings report is expected on 9 February 2027.